Tei index and neurohormonal activation in patients with incident heart failure: Serial changes and prognostic value

European Journal of Heart Failure

Volumn 8, Issue 6, 2006, Pages 599-608

  Mikkelsen, Kirsten V ^a   Møller, Jacob E ^a   Bie, Peter ^b   Ryde, Henrik ^c   Videbæk, Lars ^a   Haghfelt, Torben ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

Author keywords

Functional class; Heart failure; Natriuretic peptides; Prognosis; Tei index

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CARDIAC PATIENT; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; FEMALE; HEART VENTRICLES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 33750056713     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.11.015     Document Type: Article

References (39)

1. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
2. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
3. Cowie M.R., Wood D.A., Coats A.J.S., Thompson S.G., Suresh V., Poole-Wilson P.A., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83 (2000) 505-510
4. Senni M., Tibouilloy C.M., Rodeheffer R.J., Jacobsen S.J., Evans J.M., Bailey K.R., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted Country, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
5. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
6. Jourdain P., Funck F., Bellorini M., Guillard N., Loiret J., Thebault B., et al. Bedside natriuretic peptide and functional capacity in chronic heart failure. Eur J Heart Fail 5 (2003) 155-160
7. Lee S.C., Stevens T.L., Sandberg S.M., et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during outpatient treatment of heart failure. J Card Fail 8 (2002) 149-154
8. Latini R., Masson R., Anand I., et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25 (2004) 292-299
9. Anand I.S., Fisher L.D., Chiang Y.T., et al. Changes in brain natriuretic peptide and norephinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 107 (2003) 1278-1283
10. Wei T., Zeng C., Chen L., et al. Bedside test of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 7 (2005) 75-79
11. Lubien E., DeMaria A., Krishnaswamy P., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 105 (2002) 595-601
12. Tei C., Ling L.H., Hodge D.O., et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 26 (1995) 357-366
13. Lacorte J.C., Cabreriza S.E., Rabkin D.G., Printz B.F., Coku L., Weinberg A., et al. Correlation of the Tei index with invasive measurements of ventricular function in a porcine model. J Am Soc Echocardiogr 16 (2003) 442-447
14. Dujardin K.S., Tei C., Yeo T.C., Hodge D.O., Rossi A., and Seward J.B. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 82 (1998) 1071-1076
15. Harjai K.J., Scott L., Vivekananthan K., Nunez E., and Edupuganti R. The Tei index: a new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 15 (2002) 864-868
16. American Society of Echocardiography Committee on Standards. Recommendations for quantification of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
17. Oh J.K., Appleton C.P., Hatle L.J., Nishimura R.A., Seward J.B., and Tajik A.J. The non-invasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10 (1997) 246-270
18. Khouri S.J., Maly G.T., Suh D.D., and Walsh T.E. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17 (2004) 290-297
19. Garcia M.J., Thomas J.D., and Klein A.L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32 (1998) 865-875
20. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 19 (1998) 990-1003
21. Poulsen K., and Jorgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 39 (1974) 816-825
22. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis. 9 ed. (1994), Little Brown, Boston
23. Goldman L., Hashimoto B., Cook E.F., and Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64 (1981) 1227-1234
24. Rector T.S., and Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 124 (1992) 1017-1025
25. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
26. Kjær A., and Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 21 (2001) 661-672
27. Goetze J.P., Christoffersen C., Perko M., Arendrup H., Redfeld J.F., Kastrup J., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 9 (2003) 1105-1107
28. Clerico A. Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease. Clin Chem Lab Med 40 (2002) 752-760
29. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
30. Remes J., Tikkanen I., Fyhrquist F., and Pyörälä K. Neuroendocrine activity in untreated heart failure. Br Heart J 65 (1991) 249-255
31. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150
32. Hobbs F.D.R., Kenkre J.E., Roalfe A.K., Davis R.C., Hare R., and Davies M.K. Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23 (2002) 1867-1876
33. Swedberg K., Eneroth P., Kjekshus J., and Wilhemsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Consensus Trial Study Group. Circulation 82 (1990) 1730-1736
34. Francis G.S., Cohn J.N., Johnson G., Rector T.S., Goldman S., and Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relation to survival and the effects of therapy in V-Heft II. The V-HeFT VA Cooperative Studies Group. Circulation 87 (1993) VI-40-VI-48
35. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-Terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
36. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36 (2000) 1587-1593
37. Moller J.E., Sondergaard E., Poulsen S.H., and Egstrup K. The Doppler echocardiographic myocardial performance index predicts left-ventricular dilation and cardiac death after myocardial infarction. Cardiology 95 (2001) 105-111
38. Ono M., Tanabe K., Asanuma T., Yoshitomi H., Shimizu H., Ohta Y., et al. Doppler echocardiography-derived index of myocardial performance (TEI index). Comparison with brain natriuretic peptide levels in various heart diseases. Jpn Circ J 65 (2001) 637-642
39. Dunderdale K., Thompson D.R., Miles J.N.V., Beer S.F., and Furze G. Quality of life measurement in chronic heart failure: do we take account of the patient perspective. Eur J Heart Fail 7 (2005) 572-582